# REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)

> **NCT07174713** · NA · NOT_YET_RECRUITING · sponsor: **Western University, Canada** · enrollment: 200 (estimated)

## Conditions studied

- Asthma; Eosinophilic

## Interventions

- **BIOLOGICAL:** Biologic Therapy

## Key facts

- **NCT ID:** NCT07174713
- **Lead sponsor:** Western University, Canada
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2030-10
- **Final completion:** 2030-10
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07174713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07174713, "REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07174713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*